nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Dexbrompheniramine—Diphenhydramine—atopic dermatitis	0.223	0.274	CrCrCtD
Bisacodyl—Brompheniramine—Diphenhydramine—atopic dermatitis	0.223	0.274	CrCrCtD
Bisacodyl—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.19	0.234	CrCrCtD
Bisacodyl—Chlorphenamine—Diphenhydramine—atopic dermatitis	0.177	0.218	CrCrCtD
Bisacodyl—GPR55—GPCRs, Other—CXCR3—atopic dermatitis	0.00557	0.0507	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00506	0.046	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00451	0.0411	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00402	0.0366	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00361	0.0328	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—CCR5—atopic dermatitis	0.00349	0.0318	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL22—atopic dermatitis	0.00344	0.0313	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL27—atopic dermatitis	0.00306	0.0279	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00298	0.0271	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00291	0.0265	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL17—atopic dermatitis	0.00275	0.025	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00261	0.0237	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00237	0.0216	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL11—atopic dermatitis	0.00221	0.0202	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00211	0.0192	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00211	0.0192	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00211	0.0192	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00207	0.0189	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00181	0.0165	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCR3—atopic dermatitis	0.00181	0.0164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL22—atopic dermatitis	0.00176	0.016	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCL27—atopic dermatitis	0.00173	0.0158	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00167	0.0152	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00163	0.0149	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—NPS—atopic dermatitis	0.00161	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—TAC1—atopic dermatitis	0.00161	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCR3—atopic dermatitis	0.00158	0.0144	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL27—atopic dermatitis	0.00157	0.0143	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00144	0.0131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL17—atopic dermatitis	0.00141	0.0128	CbGpPWpGaD
Bisacodyl—Colitis—Tacrolimus—atopic dermatitis	0.00137	0.0176	CcSEcCtD
Bisacodyl—Immune system disorder—Fluocinonide—atopic dermatitis	0.00137	0.0175	CcSEcCtD
Bisacodyl—Nervous system disorder—Desonide—atopic dermatitis	0.0013	0.0167	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.0013	0.0118	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL10—atopic dermatitis	0.00128	0.0116	CbGpPWpGaD
Bisacodyl—Immune system disorder—Pimecrolimus—atopic dermatitis	0.00119	0.0153	CcSEcCtD
Bisacodyl—Malnutrition—Pimecrolimus—atopic dermatitis	0.00115	0.0147	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCL11—atopic dermatitis	0.00114	0.0103	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FCER2—atopic dermatitis	0.00112	0.0102	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL5—atopic dermatitis	0.0011	0.00999	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00106	0.0135	CcSEcCtD
Bisacodyl—Angioedema—Pimecrolimus—atopic dermatitis	0.00105	0.0134	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL22—atopic dermatitis	0.00104	0.00948	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR3—atopic dermatitis	0.00102	0.00928	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCR5—atopic dermatitis	0.000989	0.009	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000988	0.00899	CbGpPWpGaD
Bisacodyl—Dehydration—Tacrolimus—atopic dermatitis	0.000967	0.0124	CcSEcCtD
Bisacodyl—Immune system disorder—Loratadine—atopic dermatitis	0.000951	0.0122	CcSEcCtD
Bisacodyl—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.000939	0.012	CcSEcCtD
Bisacodyl—Cramp muscle—Tacrolimus—atopic dermatitis	0.000936	0.012	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL27—atopic dermatitis	0.000929	0.00845	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR3—atopic dermatitis	0.000926	0.00843	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000921	0.0118	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—TAC1—atopic dermatitis	0.000909	0.00827	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPS—atopic dermatitis	0.000909	0.00827	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000892	0.00811	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL5—atopic dermatitis	0.000845	0.00769	CbGpPWpGaD
Bisacodyl—Angioedema—Loratadine—atopic dermatitis	0.000837	0.0107	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL17—atopic dermatitis	0.000833	0.00758	CbGpPWpGaD
Bisacodyl—Headache—Desonide—atopic dermatitis	0.000833	0.0106	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—TAC1—atopic dermatitis	0.000826	0.00751	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPS—atopic dermatitis	0.000826	0.00751	CbGpPWpGaD
Bisacodyl—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.000824	0.0105	CcSEcCtD
Bisacodyl—Syncope—Loratadine—atopic dermatitis	0.000822	0.0105	CcSEcCtD
Bisacodyl—Immune system disorder—Mometasone—atopic dermatitis	0.000816	0.0104	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000811	0.0104	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCR3—atopic dermatitis	0.00081	0.00737	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Loratadine—atopic dermatitis	0.000805	0.0103	CcSEcCtD
Bisacodyl—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000794	0.0101	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000785	0.00715	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000768	0.00981	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL5—atopic dermatitis	0.000768	0.00699	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Loratadine—atopic dermatitis	0.000748	0.00956	CcSEcCtD
Bisacodyl—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000742	0.00949	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—KIF3A—atopic dermatitis	0.000742	0.00676	CbGpPWpGaD
Bisacodyl—Shock—Loratadine—atopic dermatitis	0.000736	0.00941	CcSEcCtD
Bisacodyl—Nervous system disorder—Loratadine—atopic dermatitis	0.000734	0.00938	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000721	0.00656	CbGpPWpGaD
Bisacodyl—Angioedema—Mometasone—atopic dermatitis	0.000719	0.00919	CcSEcCtD
Bisacodyl—Dizziness—Fluocinonide—atopic dermatitis	0.000712	0.0091	CcSEcCtD
Bisacodyl—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000692	0.00884	CcSEcCtD
Bisacodyl—Headache—Fluocinonide—atopic dermatitis	0.000675	0.00862	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL11—atopic dermatitis	0.000671	0.00611	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CMA1—atopic dermatitis	0.000671	0.00611	CbGpPWpGaD
Bisacodyl—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000664	0.00849	CcSEcCtD
Bisacodyl—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000664	0.00849	CcSEcCtD
Bisacodyl—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000659	0.00843	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCL10—atopic dermatitis	0.000655	0.00596	CbGpPWpGaD
Bisacodyl—Immune system disorder—Tacrolimus—atopic dermatitis	0.00065	0.0083	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000646	0.00825	CcSEcCtD
Bisacodyl—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000643	0.00821	CcSEcCtD
Bisacodyl—Dizziness—Diphenhydramine—atopic dermatitis	0.000642	0.00821	CcSEcCtD
Bisacodyl—Dizziness—Dimenhydrinate—atopic dermatitis	0.000642	0.00821	CcSEcCtD
Bisacodyl—Anaphylactic shock—Mometasone—atopic dermatitis	0.000642	0.0082	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—STAT6—atopic dermatitis	0.000631	0.00574	CbGpPWpGaD
Bisacodyl—Malnutrition—Tacrolimus—atopic dermatitis	0.000626	0.008	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCL5—atopic dermatitis	0.00062	0.00565	CbGpPWpGaD
Bisacodyl—Vomiting—Dimenhydrinate—atopic dermatitis	0.000617	0.00789	CcSEcCtD
Bisacodyl—Vomiting—Diphenhydramine—atopic dermatitis	0.000617	0.00789	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000612	0.00782	CcSEcCtD
Bisacodyl—Headache—Diphenhydramine—atopic dermatitis	0.000608	0.00778	CcSEcCtD
Bisacodyl—Headache—Dimenhydrinate—atopic dermatitis	0.000608	0.00778	CcSEcCtD
Bisacodyl—Muscle spasms—Tacrolimus—atopic dermatitis	0.000602	0.00769	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CXCL8—atopic dermatitis	0.000598	0.00544	CbGpPWpGaD
Bisacodyl—Vomiting—Pimecrolimus—atopic dermatitis	0.000597	0.00763	CcSEcCtD
Bisacodyl—Abdominal pain—Loratadine—atopic dermatitis	0.000591	0.00756	CcSEcCtD
Bisacodyl—Headache—Pimecrolimus—atopic dermatitis	0.000588	0.00752	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00058	0.00742	CcSEcCtD
Bisacodyl—Nausea—Dimenhydrinate—atopic dermatitis	0.000577	0.00737	CcSEcCtD
Bisacodyl—Nausea—Diphenhydramine—atopic dermatitis	0.000577	0.00737	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCL5—atopic dermatitis	0.000563	0.00513	CbGpPWpGaD
Bisacodyl—Syncope—Tacrolimus—atopic dermatitis	0.000561	0.00717	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR5—atopic dermatitis	0.000559	0.00509	CbGpPWpGaD
Bisacodyl—Nausea—Pimecrolimus—atopic dermatitis	0.000558	0.00713	CcSEcCtD
Bisacodyl—Loss of consciousness—Tacrolimus—atopic dermatitis	0.00055	0.00703	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR3—atopic dermatitis	0.000547	0.00498	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000525	0.00671	CcSEcCtD
Bisacodyl—Diarrhoea—Loratadine—atopic dermatitis	0.000512	0.00654	CcSEcCtD
Bisacodyl—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000511	0.00653	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR5—atopic dermatitis	0.000508	0.00462	CbGpPWpGaD
Bisacodyl—Abdominal pain—Mometasone—atopic dermatitis	0.000507	0.00649	CcSEcCtD
Bisacodyl—Shock—Tacrolimus—atopic dermatitis	0.000503	0.00642	CcSEcCtD
Bisacodyl—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000501	0.0064	CcSEcCtD
Bisacodyl—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000495	0.00633	CcSEcCtD
Bisacodyl—Dizziness—Loratadine—atopic dermatitis	0.000495	0.00632	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NPS—atopic dermatitis	0.000488	0.00444	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TAC1—atopic dermatitis	0.000488	0.00444	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCR3—atopic dermatitis	0.000478	0.00435	CbGpPWpGaD
Bisacodyl—Vomiting—Loratadine—atopic dermatitis	0.000476	0.00608	CcSEcCtD
Bisacodyl—Headache—Loratadine—atopic dermatitis	0.000469	0.00599	CcSEcCtD
Bisacodyl—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00046	0.00588	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL5—atopic dermatitis	0.000453	0.00413	CbGpPWpGaD
Bisacodyl—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000445	0.00568	CcSEcCtD
Bisacodyl—Nausea—Loratadine—atopic dermatitis	0.000444	0.00568	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000441	0.00564	CcSEcCtD
Bisacodyl—Diarrhoea—Mometasone—atopic dermatitis	0.000439	0.00561	CcSEcCtD
Bisacodyl—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000427	0.00546	CcSEcCtD
Bisacodyl—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000421	0.00538	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000418	0.00534	CcSEcCtD
Bisacodyl—Vomiting—Mometasone—atopic dermatitis	0.000408	0.00522	CcSEcCtD
Bisacodyl—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000405	0.00518	CcSEcCtD
Bisacodyl—Abdominal pain—Tacrolimus—atopic dermatitis	0.000404	0.00516	CcSEcCtD
Bisacodyl—Headache—Mometasone—atopic dermatitis	0.000402	0.00514	CcSEcCtD
Bisacodyl—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000399	0.0051	CcSEcCtD
Bisacodyl—Malnutrition—Hydrocortisone—atopic dermatitis	0.00039	0.00499	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CXCL10—atopic dermatitis	0.000387	0.00352	CbGpPWpGaD
Bisacodyl—Nausea—Mometasone—atopic dermatitis	0.000381	0.00487	CcSEcCtD
Bisacodyl—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000381	0.00487	CcSEcCtD
Bisacodyl—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000376	0.00481	CcSEcCtD
Bisacodyl—Malnutrition—Methylprednisolone—atopic dermatitis	0.000367	0.00469	CcSEcCtD
Bisacodyl—Angioedema—Prednisolone—atopic dermatitis	0.000365	0.00467	CcSEcCtD
Bisacodyl—Syncope—Prednisolone—atopic dermatitis	0.000359	0.00458	CcSEcCtD
Bisacodyl—Angioedema—Hydrocortisone—atopic dermatitis	0.000357	0.00456	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisolone—atopic dermatitis	0.000351	0.00449	CcSEcCtD
Bisacodyl—Syncope—Hydrocortisone—atopic dermatitis	0.00035	0.00448	CcSEcCtD
Bisacodyl—Diarrhoea—Tacrolimus—atopic dermatitis	0.00035	0.00447	CcSEcCtD
Bisacodyl—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000343	0.00439	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000338	0.00308	CbGpPWpGaD
Bisacodyl—Dizziness—Tacrolimus—atopic dermatitis	0.000338	0.00432	CcSEcCtD
Bisacodyl—Angioedema—Triamcinolone—atopic dermatitis	0.000336	0.00429	CcSEcCtD
Bisacodyl—Angioedema—Methylprednisolone—atopic dermatitis	0.000335	0.00428	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCL5—atopic dermatitis	0.000333	0.00303	CbGpPWpGaD
Bisacodyl—Syncope—Triamcinolone—atopic dermatitis	0.00033	0.00421	CcSEcCtD
Bisacodyl—Syncope—Methylprednisolone—atopic dermatitis	0.000329	0.00421	CcSEcCtD
Bisacodyl—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000326	0.00417	CcSEcCtD
Bisacodyl—Vomiting—Tacrolimus—atopic dermatitis	0.000325	0.00415	CcSEcCtD
Bisacodyl—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000323	0.00413	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—IL2—atopic dermatitis	0.000323	0.00294	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000322	0.00412	CcSEcCtD
Bisacodyl—Shock—Prednisolone—atopic dermatitis	0.000321	0.0041	CcSEcCtD
Bisacodyl—Headache—Tacrolimus—atopic dermatitis	0.00032	0.00409	CcSEcCtD
Bisacodyl—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000319	0.00407	CcSEcCtD
Bisacodyl—Shock—Hydrocortisone—atopic dermatitis	0.000314	0.00401	CcSEcCtD
Bisacodyl—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000313	0.00399	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NGF—atopic dermatitis	0.000308	0.00281	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL8—atopic dermatitis	0.000307	0.00279	CbGpPWpGaD
Bisacodyl—Angioedema—Dexamethasone—atopic dermatitis	0.000305	0.0039	CcSEcCtD
Bisacodyl—Angioedema—Betamethasone—atopic dermatitis	0.000305	0.0039	CcSEcCtD
Bisacodyl—Nausea—Tacrolimus—atopic dermatitis	0.000303	0.00388	CcSEcCtD
Bisacodyl—Immune system disorder—Prednisone—atopic dermatitis	0.000301	0.00385	CcSEcCtD
Bisacodyl—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.0003	0.00384	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR5—atopic dermatitis	0.0003	0.00273	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000299	0.00383	CcSEcCtD
Bisacodyl—Syncope—Betamethasone—atopic dermatitis	0.000299	0.00382	CcSEcCtD
Bisacodyl—Syncope—Dexamethasone—atopic dermatitis	0.000299	0.00382	CcSEcCtD
Bisacodyl—Shock—Triamcinolone—atopic dermatitis	0.000295	0.00377	CcSEcCtD
Bisacodyl—Shock—Methylprednisolone—atopic dermatitis	0.000295	0.00377	CcSEcCtD
Bisacodyl—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000294	0.00375	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL2—atopic dermatitis	0.000293	0.00267	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000293	0.00375	CcSEcCtD
Bisacodyl—Loss of consciousness—Betamethasone—atopic dermatitis	0.000293	0.00375	CcSEcCtD
Bisacodyl—Malnutrition—Prednisone—atopic dermatitis	0.000291	0.00371	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000275	0.00352	CcSEcCtD
Bisacodyl—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000272	0.00348	CcSEcCtD
Bisacodyl—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000272	0.00348	CcSEcCtD
Bisacodyl—Shock—Betamethasone—atopic dermatitis	0.000268	0.00342	CcSEcCtD
Bisacodyl—Shock—Dexamethasone—atopic dermatitis	0.000268	0.00342	CcSEcCtD
Bisacodyl—Nervous system disorder—Betamethasone—atopic dermatitis	0.000267	0.00341	CcSEcCtD
Bisacodyl—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000267	0.00341	CcSEcCtD
Bisacodyl—Angioedema—Prednisone—atopic dermatitis	0.000265	0.00339	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000261	0.00333	CcSEcCtD
Bisacodyl—Syncope—Prednisone—atopic dermatitis	0.000261	0.00333	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisone—atopic dermatitis	0.000255	0.00326	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NFKBIA—atopic dermatitis	0.000254	0.00231	CbGpPWpGaD
Bisacodyl—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000252	0.00322	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000245	0.00313	CcSEcCtD
Bisacodyl—Hypersensitivity—Prednisolone—atopic dermatitis	0.00024	0.00307	CcSEcCtD
Bisacodyl—Anaphylactic shock—Prednisone—atopic dermatitis	0.000237	0.00303	CcSEcCtD
Bisacodyl—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000237	0.00303	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000235	0.003	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000235	0.003	CcSEcCtD
Bisacodyl—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000235	0.003	CcSEcCtD
Bisacodyl—Shock—Prednisone—atopic dermatitis	0.000233	0.00298	CcSEcCtD
Bisacodyl—Nervous system disorder—Prednisone—atopic dermatitis	0.000233	0.00297	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000223	0.00285	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000223	0.00285	CcSEcCtD
Bisacodyl—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000221	0.00283	CcSEcCtD
Bisacodyl—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000221	0.00282	CcSEcCtD
Bisacodyl—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000218	0.00279	CcSEcCtD
Bisacodyl—Dizziness—Prednisolone—atopic dermatitis	0.000216	0.00276	CcSEcCtD
Bisacodyl—Abdominal pain—Dexamethasone—atopic dermatitis	0.000215	0.00275	CcSEcCtD
Bisacodyl—Abdominal pain—Betamethasone—atopic dermatitis	0.000215	0.00275	CcSEcCtD
Bisacodyl—Dizziness—Hydrocortisone—atopic dermatitis	0.000211	0.00269	CcSEcCtD
Bisacodyl—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000205	0.00262	CcSEcCtD
Bisacodyl—Headache—Prednisolone—atopic dermatitis	0.000204	0.00261	CcSEcCtD
Bisacodyl—Vomiting—Hydrocortisone—atopic dermatitis	0.000203	0.00259	CcSEcCtD
Bisacodyl—Headache—Hydrocortisone—atopic dermatitis	0.0002	0.00255	CcSEcCtD
Bisacodyl—Dizziness—Triamcinolone—atopic dermatitis	0.000198	0.00254	CcSEcCtD
Bisacodyl—Dizziness—Methylprednisolone—atopic dermatitis	0.000198	0.00253	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000194	0.00248	CcSEcCtD
Bisacodyl—Nausea—Prednisolone—atopic dermatitis	0.000194	0.00248	CcSEcCtD
Bisacodyl—Vomiting—Triamcinolone—atopic dermatitis	0.000191	0.00244	CcSEcCtD
Bisacodyl—Vomiting—Methylprednisolone—atopic dermatitis	0.00019	0.00243	CcSEcCtD
Bisacodyl—Nausea—Hydrocortisone—atopic dermatitis	0.000189	0.00242	CcSEcCtD
Bisacodyl—Headache—Triamcinolone—atopic dermatitis	0.000188	0.0024	CcSEcCtD
Bisacodyl—Headache—Methylprednisolone—atopic dermatitis	0.000188	0.0024	CcSEcCtD
Bisacodyl—Abdominal pain—Prednisone—atopic dermatitis	0.000187	0.0024	CcSEcCtD
Bisacodyl—Diarrhoea—Betamethasone—atopic dermatitis	0.000186	0.00238	CcSEcCtD
Bisacodyl—Diarrhoea—Dexamethasone—atopic dermatitis	0.000186	0.00238	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CXCL8—atopic dermatitis	0.000181	0.00165	CbGpPWpGaD
Bisacodyl—Dizziness—Dexamethasone—atopic dermatitis	0.00018	0.0023	CcSEcCtD
Bisacodyl—Dizziness—Betamethasone—atopic dermatitis	0.00018	0.0023	CcSEcCtD
Bisacodyl—Nausea—Triamcinolone—atopic dermatitis	0.000178	0.00228	CcSEcCtD
Bisacodyl—Nausea—Methylprednisolone—atopic dermatitis	0.000178	0.00227	CcSEcCtD
Bisacodyl—Hypersensitivity—Prednisone—atopic dermatitis	0.000175	0.00223	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL2—atopic dermatitis	0.000173	0.00158	CbGpPWpGaD
Bisacodyl—Vomiting—Dexamethasone—atopic dermatitis	0.000173	0.00221	CcSEcCtD
Bisacodyl—Vomiting—Betamethasone—atopic dermatitis	0.000173	0.00221	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL6—atopic dermatitis	0.000172	0.00157	CbGpPWpGaD
Bisacodyl—Headache—Betamethasone—atopic dermatitis	0.000171	0.00218	CcSEcCtD
Bisacodyl—Headache—Dexamethasone—atopic dermatitis	0.000171	0.00218	CcSEcCtD
Bisacodyl—Diarrhoea—Prednisone—atopic dermatitis	0.000162	0.00207	CcSEcCtD
Bisacodyl—Nausea—Dexamethasone—atopic dermatitis	0.000162	0.00207	CcSEcCtD
Bisacodyl—Nausea—Betamethasone—atopic dermatitis	0.000162	0.00207	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MAPK8—atopic dermatitis	0.000159	0.00145	CbGpPWpGaD
Bisacodyl—Dizziness—Prednisone—atopic dermatitis	0.000157	0.002	CcSEcCtD
Bisacodyl—Vomiting—Prednisone—atopic dermatitis	0.000151	0.00193	CcSEcCtD
Bisacodyl—Headache—Prednisone—atopic dermatitis	0.000149	0.0019	CcSEcCtD
Bisacodyl—Nausea—Prednisone—atopic dermatitis	0.000141	0.0018	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL6—atopic dermatitis	0.000102	0.000927	CbGpPWpGaD
